Meigs’ syndrome is a rare medical condition characterized by a triad of symptoms that typically incorporate the existence of a non-malignant ovarian growth, pleural effusion, and ascites. This syndrome was first described by the American gynecologist Joe Vincent Meigs in 1937, and its recognition has since played a crucial role in gynecology and oncology.
Meigs’ syndrome often presents a diagnostic challenge due to its similarity to other more severe conditions, such as ovarian cancer, making accurate diagnosis and prompt intervention essential for patient care.
Epidemiology
Incidence:
Meigs syndrome is rare, accounting for a small fraction of ovarian tumors and pleural effusions.
Meigs syndrome occurs in approximately 1% of all ovarian tumors and is most frequently linked with ovarian fibromas, identified in 2-5% of surgically removed ovarian tumors.
The exact incidence of this syndrome is not well-established due to its rarity.
Age and Gender:
Meigs syndrome most commonly affects women, with most reported cases occurring in females.
It predominantly occurs in women between 30 and 60 years, although it can affect women of all ages.
Tumor Type:
The ovarian tumor associated with this syndrome is typically a benign fibroma.
Other less common ovarian tumors, such as thecoma or granulosa cell tumors, can also be associated with this syndrome.
Anatomy
Pathophysiology
Tumor Growth:
Meigs Syndrome typically occurs in women with a benign ovarian tumor, most commonly a fibroma. These tumors are solid and arise from the connective tissue of the ovary.
As the tumor grows, it can compress blood vessels and lymphatic vessels within the ovary, leading to impaired blood and lymphatic drainage from the affected ovary.
Increased Permeability:
The ovarian tumor may stimulate the release of certain substances or inflammatory mediators to enhance the blood vessels permeability within the tumor and the surrounding tissues.
This increased permeability can leak fluid, protein, and blood components into the abdominal cavity (ascites) and the pleural space (pleural effusion).
Fluid Accumulation:
Ascites develops due to the buildup of fluid within the peritoneal cavity. The increased permeability of blood vessels allows fluid to escape into the abdominal space.
Pleural effusion occurs when fluid leaks into the pleural space around the lungs. This can cause compression of the lungs, leading to breathing difficulties.
Ovarian Tumor Characteristics:
The specific characteristics of the ovarian tumor, such as its size and location, can contribute to developing this Syndrome. Larger tumors are more likely to cause compression and vascular compromise.
Fibromas are usually slow-growing and benign, so they do not invade surrounding tissues or metastasize.
Etiology
Ovarian Tumor: Meigs syndrome is primarily characterized by the occurrence of a non-cancerous ovarian growth, usually identified as a fibroma. However, other types of tumors like thecoma or granulosa cell tumors can also be involved. These tumors arise from the connective tissue or stromal cells of the ovary.
Pleural Effusion: Meigs syndrome also involves the accumulation of fluid within the pleural cavity, known as pleural effusion. This can lead to chest pain, cough, and shortness of breath.
Ascites is fluid accumulation within the peritoneal cavity, causing abdominal distention and discomfort. In this syndrome, ascites is often present along with pleural effusion.
Tumor Pressure: The presence of the ovarian tumor can exert pressure on nearby blood vessels and lymphatic channels. This pressure may disrupt the normal flow of fluids within the body, leading to ascites and pleural effusion.
Inflammatory Mediators: Some researchers suggest that the tumor itself may produce inflammatory mediators or substances that contribute to fluid accumulation in the peritoneal and pleural spaces.
Genetics
Prognostic Factors
Tumor Characteristics: The size and nature of the ovarian tumor play a crucial role in the prognosis. Larger tumors may be associated with more severe symptoms and complications, potentially affecting the prognosis.
Tumor Histology: The histological type of the ovarian tumor can influence the prognosis. Most Meigs syndrome cases involve benign fibromas, which have an excellent prognosis. However, in rare cases, ovarian malignancies may mimic this syndrome, leading to a worse prognosis.
Underlying Health Status: The patient’s overall health, including other medical conditions, can influence the prognosis and the ability to tolerate surgery and treatment.
Clinical History
Age group
Meigs syndrome primarily affects adults, typically in women in their reproductive years or postmenopausal. The age group for meigs syndrome is most commonly between 30 and 50 years old. However, it’s important to note that this is a general age range, and cases outside of this range can still occur, albeit less frequently.
Physical Examination
Abdominal Examination:
Abdominal Distension: The most prominent physical finding in this syndrome is abdominal distension due to the accumulation of ascitic fluid. The abdomen may appear enlarged and tense.
Palpable Pelvic Mass: A firm, non-tender pelvic mass, often arising from one of the ovaries (usually a fibroma), may be palpable during a pelvic examination.
Tenderness: Some patients may experience mild tenderness or discomfort in the lower abdomen, especially if the mass is large or if there is associated torsion or inflammation.
Imaging Studies: Ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) can help confirm the presence of an ovarian mass and assess the extent of ascites and pleural effusion.
Laboratory Tests: Routine blood tests can show elevated cancer markers (e.g., CA-125), but these markers are not specific to this syndrome.
Histopathology: Definitive diagnosis often requires surgical removal of the ovarian mass, followed by histopathological examination to confirm the presence of a benign tumor.
Age group
Associated comorbidity
Associated activity
Ovarian Tumor: The presence of a benign ovarian tumour, most frequently a fibroma, is the leading cause of this disease. These tumors can grow quite large and cause abdominal discomfort or pain.
Pleural Effusion: Another feature of this syndrome involves the fluid accumulation in the pleural cavity, which is the area surrounding the lungs. This medical condition is referred to as pleural effusion and can result in manifestations like difficulty in breathing, chest discomfort, or an ongoing cough.
Ascites: Ascites is the fluid accumulation within the abdominal cavity, leading to abdominal swelling and discomfort.
Acuity of presentation
Subtle or Insidious Onset:
Meigs syndrome can sometimes have a slow and insidious onset, with symptoms developing gradually over weeks or even months.
Patients may initially experience mild discomfort or bloating in the lower abdomen.
Abdominal Discomfort:
Many individuals with this syndrome complain of abdominal discomfort or pain, which may be intermittent or persistent.
This discomfort is often located in the lower abdomen and may be mistaken for gastrointestinal issues.
Ascites:
Ascites is the condition characterized by the fluid accumulation within the abdominal cavity, represents a distinguishing characteristic of this syndrome.
As ascites worsens, patients may notice abdominal distension, weight gain, and a feeling of fullness.
Pleural Effusion:
pleural effusion is the fluid accumulation around the lungs, may lead to various symptoms including coughing, difficulty breathing, and chest discomfort.
These respiratory symptoms may be subtle initially but can become more pronounced as the pleural effusion worsens.
Elevated CA-125 Levels:
In some cases, blood tests may reveal elevated levels of CA-125, a tumor marker associated with ovarian cancer. This can further complicate the diagnosis.
Differential Diagnoses
Ovarian Cancer: Ovarian cancer can present with similar symptoms, including pleural effusion and ascites. Differentiating between benign ovarian tumors and ovarian cancer is crucial, and this often requires imaging studies, biopsy, and tumor markers (e.g., CA-125).
Tuberculosis (TB): TB can cause pleural effusion and ascites. It is especially important to consider TB in regions where it is prevalent.
Liver Cirrhosis: Cirrhosis can result in ascites due to liver dysfunction and increased abdominal pressure. It can also lead to pleural effusion in some cases.
Peritoneal Carcinomatosis: It involves spreading cancer cells throughout the peritoneal cavity, causing ascites and sometimes pleural effusion.
Nephrotic Syndrome: This kidney disorder can lead to generalized edema, including pleural effusion and ascites.
Endometriosis: Although less common, endometriosis can present with ovarian masses and ascites.
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Diagnosis and Evaluation:
The diagnosis of this syndrome is typically made based on clinical presentation, imaging studies (ultrasound, CT scan), and laboratory tests.
Ascitic fluid analysis and pleural fluid analysis are essential to rule out malignancy.
Stabilization:
If the patient is in respiratory distress due to pleural effusion, initial stabilization may involve pleural fluid drainage to relieve respiratory symptoms.
Surgical Intervention:
The primary treatment for this syndrome is surgical removal of the ovarian tumor (ovarian cystectomy or oophorectomy).
A laparoscopic approach is often preferred when feasible, resulting in reduced postoperative pain and quicker recovery periods.
Histological Examination:
The removed ovarian tumor should be sent for histological examination to confirm its benign nature, a characteristic of this syndrome.
Resolution of Ascites and Pleural Effusion:
Following the surgical excision of the ovarian mass, ascites and pleural effusion typically resolve rapidly over the following weeks.
Continued monitoring with imaging studies and clinical evaluation is essential to confirm resolution.
Follow-Up:
Postoperative follow-up is crucial to monitor for any ascites or pleural effusion recurrence.
Long-term surveillance may also be necessary to detect any potential complications or recurrence of the ovarian tumor.
Supportive Care:
Patients may require supportive care during their recovery, including pain management, nutritional support, and respiratory therapy if respiratory compromise was severe before surgery.
Consideration of Malignancy:
In rare cases, this syndrome may mimic malignant conditions, so a careful evaluation and workup are essential to rule out ovarian malignancies.
After surgery ensure that the patient’s room is kept clean, and infection control measures are strictly followed.
Rehabilitation:
Individuals in the process of post-surgical recovery can experience improved strength and mobility through the utilization of physical therapy and rehabilitation services.
The environment for rehabilitation should be equipped with appropriate exercise equipment and supportive care.
Emotional Support:
Meigs syndrome and its treatment can be physically and emotionally challenging. Providing a supportive and empathetic environment is crucial.
Considerations for counseling services or support groups may benefit patients and their families.
Nutritional Support:
Patients recovering from this syndrome may need specialized diets or nutritional support to aid in their recovery.
Ensure that the hospital or care facility can provide appropriate dietary options.
Home Environment:
After discharge from the hospital, patients may need modifications to their home environment to accommodate their recovery needs, such as handrails or adaptive equipment.
Home healthcare services may be necessary for individuals who require ongoing medical care and monitoring.
surgical-management
Surgical Consultation: Refer the patient to a gynecologic surgeon or a surgical oncologist experienced in managing this Syndrome.
Surgery: Typically, surgery is the primary treatment for Meigs Syndrome. The procedure may involve unilateral or bilateral salpingo-oophorectomy (surgical extraction of the affected ovary and associated fallopian tube.) and the removal of the ovarian fibroma.
laparotomy: A laparotomy for Meigs Syndrome is a surgical procedure performed to treat this rare condition, which typically involves the removal of a tumor associated with this Syndrome, such as a fibroma, along with the removal of a large amount of ascitic fluid that has accumulated in the abdominal cavity. This procedure aims to relieve symptoms and improve the patient’s overall health.
Postoperative Care:
Monitoring: After surgery, closely monitor the patient’s recovery in the hospital, including vital signs, pain management, and fluid balance.
Pathological Examination: Analyze the biopsy samples to confirm the presence of ovarian fibroma and rule out malignancy.
diagnosis
Clinical Evaluation: The first stage entails a thorough examination of the patient’s medical records and a comprehensive physical assessment. If symptoms like abdominal swelling, pleuritic chest discomfort, and difficulty in breathing are observed, it could indicate the possibility of this syndrome.
Imaging: Radiological techniques like ultrasound, CT scans, or MRI can be employed to visualize the ovarian mass, confirm the presence of ascites and pleural effusion, and rule out other potential causes of these symptoms.
Laboratory Tests: Blood tests, including tumor markers (e.g., CA-125), may be performed to aid in the diagnosis and rule out malignancy.
Treatment:
Surgery: The main approach to address this syndrome involves the surgical extraction of the ovarian tumor. This procedure is often performed via laparotomy or laparoscopy, depending on the size and characteristics of the tumor. In most cases, the tumor is benign (fibroma) and can be completely excised.
Paracentesis: In cases of significant ascites, a medical procedure known as paracentesis, this process entails extracting fluid from the abdominal cavity, can be undertaken to alleviate symptoms and enable surgical interventions.
Thoracentesis: If pleural effusion is causing respiratory distress, thoracentesis (draining of fluid from the pleural space) may be necessary to improve lung function.
Histopathological Examination:
The excised ovarian tumor is sent for histopathological examination to confirm its benign nature and rule out malignancy.
Postoperative Care:
After surgery, patients are closely monitored for any complications, and pain management and wound care are provided as necessary.
Patients with significant pleural effusion or ascites may require ongoing management to address these issues.
Follow-up:
Regular post-treatment check-ups are crucial for overseeing the patient’s recuperation and preventing any reoccurrence of this medical condition.
Imaging studies and clinical assessments may be scheduled at specified intervals to check for any signs of tumor recurrence or other complications.
Patient Education and Support:
Patients should be educated about their condition, treatment, and follow-up care’s importance.
Meigs’ syndrome is a rare medical condition characterized by a triad of symptoms that typically incorporate the existence of a non-malignant ovarian growth, pleural effusion, and ascites. This syndrome was first described by the American gynecologist Joe Vincent Meigs in 1937, and its recognition has since played a crucial role in gynecology and oncology.
Meigs’ syndrome often presents a diagnostic challenge due to its similarity to other more severe conditions, such as ovarian cancer, making accurate diagnosis and prompt intervention essential for patient care.
Incidence:
Meigs syndrome is rare, accounting for a small fraction of ovarian tumors and pleural effusions.
Meigs syndrome occurs in approximately 1% of all ovarian tumors and is most frequently linked with ovarian fibromas, identified in 2-5% of surgically removed ovarian tumors.
The exact incidence of this syndrome is not well-established due to its rarity.
Age and Gender:
Meigs syndrome most commonly affects women, with most reported cases occurring in females.
It predominantly occurs in women between 30 and 60 years, although it can affect women of all ages.
Tumor Type:
The ovarian tumor associated with this syndrome is typically a benign fibroma.
Other less common ovarian tumors, such as thecoma or granulosa cell tumors, can also be associated with this syndrome.
Tumor Growth:
Meigs Syndrome typically occurs in women with a benign ovarian tumor, most commonly a fibroma. These tumors are solid and arise from the connective tissue of the ovary.
As the tumor grows, it can compress blood vessels and lymphatic vessels within the ovary, leading to impaired blood and lymphatic drainage from the affected ovary.
Increased Permeability:
The ovarian tumor may stimulate the release of certain substances or inflammatory mediators to enhance the blood vessels permeability within the tumor and the surrounding tissues.
This increased permeability can leak fluid, protein, and blood components into the abdominal cavity (ascites) and the pleural space (pleural effusion).
Fluid Accumulation:
Ascites develops due to the buildup of fluid within the peritoneal cavity. The increased permeability of blood vessels allows fluid to escape into the abdominal space.
Pleural effusion occurs when fluid leaks into the pleural space around the lungs. This can cause compression of the lungs, leading to breathing difficulties.
Ovarian Tumor Characteristics:
The specific characteristics of the ovarian tumor, such as its size and location, can contribute to developing this Syndrome. Larger tumors are more likely to cause compression and vascular compromise.
Fibromas are usually slow-growing and benign, so they do not invade surrounding tissues or metastasize.
Ovarian Tumor: Meigs syndrome is primarily characterized by the occurrence of a non-cancerous ovarian growth, usually identified as a fibroma. However, other types of tumors like thecoma or granulosa cell tumors can also be involved. These tumors arise from the connective tissue or stromal cells of the ovary.
Pleural Effusion: Meigs syndrome also involves the accumulation of fluid within the pleural cavity, known as pleural effusion. This can lead to chest pain, cough, and shortness of breath.
Ascites is fluid accumulation within the peritoneal cavity, causing abdominal distention and discomfort. In this syndrome, ascites is often present along with pleural effusion.
Tumor Pressure: The presence of the ovarian tumor can exert pressure on nearby blood vessels and lymphatic channels. This pressure may disrupt the normal flow of fluids within the body, leading to ascites and pleural effusion.
Inflammatory Mediators: Some researchers suggest that the tumor itself may produce inflammatory mediators or substances that contribute to fluid accumulation in the peritoneal and pleural spaces.
Tumor Characteristics: The size and nature of the ovarian tumor play a crucial role in the prognosis. Larger tumors may be associated with more severe symptoms and complications, potentially affecting the prognosis.
Tumor Histology: The histological type of the ovarian tumor can influence the prognosis. Most Meigs syndrome cases involve benign fibromas, which have an excellent prognosis. However, in rare cases, ovarian malignancies may mimic this syndrome, leading to a worse prognosis.
Underlying Health Status: The patient’s overall health, including other medical conditions, can influence the prognosis and the ability to tolerate surgery and treatment.
Age group
Meigs syndrome primarily affects adults, typically in women in their reproductive years or postmenopausal. The age group for meigs syndrome is most commonly between 30 and 50 years old. However, it’s important to note that this is a general age range, and cases outside of this range can still occur, albeit less frequently.
Abdominal Examination:
Abdominal Distension: The most prominent physical finding in this syndrome is abdominal distension due to the accumulation of ascitic fluid. The abdomen may appear enlarged and tense.
Palpable Pelvic Mass: A firm, non-tender pelvic mass, often arising from one of the ovaries (usually a fibroma), may be palpable during a pelvic examination.
Tenderness: Some patients may experience mild tenderness or discomfort in the lower abdomen, especially if the mass is large or if there is associated torsion or inflammation.
Imaging Studies: Ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) can help confirm the presence of an ovarian mass and assess the extent of ascites and pleural effusion.
Laboratory Tests: Routine blood tests can show elevated cancer markers (e.g., CA-125), but these markers are not specific to this syndrome.
Histopathology: Definitive diagnosis often requires surgical removal of the ovarian mass, followed by histopathological examination to confirm the presence of a benign tumor.
Subtle or Insidious Onset:
Meigs syndrome can sometimes have a slow and insidious onset, with symptoms developing gradually over weeks or even months.
Patients may initially experience mild discomfort or bloating in the lower abdomen.
Abdominal Discomfort:
Many individuals with this syndrome complain of abdominal discomfort or pain, which may be intermittent or persistent.
This discomfort is often located in the lower abdomen and may be mistaken for gastrointestinal issues.
Ascites:
Ascites is the condition characterized by the fluid accumulation within the abdominal cavity, represents a distinguishing characteristic of this syndrome.
As ascites worsens, patients may notice abdominal distension, weight gain, and a feeling of fullness.
Pleural Effusion:
pleural effusion is the fluid accumulation around the lungs, may lead to various symptoms including coughing, difficulty breathing, and chest discomfort.
These respiratory symptoms may be subtle initially but can become more pronounced as the pleural effusion worsens.
Elevated CA-125 Levels:
In some cases, blood tests may reveal elevated levels of CA-125, a tumor marker associated with ovarian cancer. This can further complicate the diagnosis.
Ovarian Tumor: The presence of a benign ovarian tumour, most frequently a fibroma, is the leading cause of this disease. These tumors can grow quite large and cause abdominal discomfort or pain.
Pleural Effusion: Another feature of this syndrome involves the fluid accumulation in the pleural cavity, which is the area surrounding the lungs. This medical condition is referred to as pleural effusion and can result in manifestations like difficulty in breathing, chest discomfort, or an ongoing cough.
Ascites: Ascites is the fluid accumulation within the abdominal cavity, leading to abdominal swelling and discomfort.
Ovarian Cancer: Ovarian cancer can present with similar symptoms, including pleural effusion and ascites. Differentiating between benign ovarian tumors and ovarian cancer is crucial, and this often requires imaging studies, biopsy, and tumor markers (e.g., CA-125).
Tuberculosis (TB): TB can cause pleural effusion and ascites. It is especially important to consider TB in regions where it is prevalent.
Liver Cirrhosis: Cirrhosis can result in ascites due to liver dysfunction and increased abdominal pressure. It can also lead to pleural effusion in some cases.
Peritoneal Carcinomatosis: It involves spreading cancer cells throughout the peritoneal cavity, causing ascites and sometimes pleural effusion.
Nephrotic Syndrome: This kidney disorder can lead to generalized edema, including pleural effusion and ascites.
Endometriosis: Although less common, endometriosis can present with ovarian masses and ascites.
Diagnosis and Evaluation:
The diagnosis of this syndrome is typically made based on clinical presentation, imaging studies (ultrasound, CT scan), and laboratory tests.
Ascitic fluid analysis and pleural fluid analysis are essential to rule out malignancy.
Stabilization:
If the patient is in respiratory distress due to pleural effusion, initial stabilization may involve pleural fluid drainage to relieve respiratory symptoms.
Surgical Intervention:
The primary treatment for this syndrome is surgical removal of the ovarian tumor (ovarian cystectomy or oophorectomy).
A laparoscopic approach is often preferred when feasible, resulting in reduced postoperative pain and quicker recovery periods.
Histological Examination:
The removed ovarian tumor should be sent for histological examination to confirm its benign nature, a characteristic of this syndrome.
Resolution of Ascites and Pleural Effusion:
Following the surgical excision of the ovarian mass, ascites and pleural effusion typically resolve rapidly over the following weeks.
Continued monitoring with imaging studies and clinical evaluation is essential to confirm resolution.
Follow-Up:
Postoperative follow-up is crucial to monitor for any ascites or pleural effusion recurrence.
Long-term surveillance may also be necessary to detect any potential complications or recurrence of the ovarian tumor.
Supportive Care:
Patients may require supportive care during their recovery, including pain management, nutritional support, and respiratory therapy if respiratory compromise was severe before surgery.
Consideration of Malignancy:
In rare cases, this syndrome may mimic malignant conditions, so a careful evaluation and workup are essential to rule out ovarian malignancies.
OB/GYN and Women\'s Health
Postoperative Care:
After surgery ensure that the patient’s room is kept clean, and infection control measures are strictly followed.
Rehabilitation:
Individuals in the process of post-surgical recovery can experience improved strength and mobility through the utilization of physical therapy and rehabilitation services.
The environment for rehabilitation should be equipped with appropriate exercise equipment and supportive care.
Emotional Support:
Meigs syndrome and its treatment can be physically and emotionally challenging. Providing a supportive and empathetic environment is crucial.
Considerations for counseling services or support groups may benefit patients and their families.
Nutritional Support:
Patients recovering from this syndrome may need specialized diets or nutritional support to aid in their recovery.
Ensure that the hospital or care facility can provide appropriate dietary options.
Home Environment:
After discharge from the hospital, patients may need modifications to their home environment to accommodate their recovery needs, such as handrails or adaptive equipment.
Home healthcare services may be necessary for individuals who require ongoing medical care and monitoring.
OB/GYN and Women\'s Health
Surgical Consultation: Refer the patient to a gynecologic surgeon or a surgical oncologist experienced in managing this Syndrome.
Surgery: Typically, surgery is the primary treatment for Meigs Syndrome. The procedure may involve unilateral or bilateral salpingo-oophorectomy (surgical extraction of the affected ovary and associated fallopian tube.) and the removal of the ovarian fibroma.
laparotomy: A laparotomy for Meigs Syndrome is a surgical procedure performed to treat this rare condition, which typically involves the removal of a tumor associated with this Syndrome, such as a fibroma, along with the removal of a large amount of ascitic fluid that has accumulated in the abdominal cavity. This procedure aims to relieve symptoms and improve the patient’s overall health.
Postoperative Care:
Monitoring: After surgery, closely monitor the patient’s recovery in the hospital, including vital signs, pain management, and fluid balance.
Pathological Examination: Analyze the biopsy samples to confirm the presence of ovarian fibroma and rule out malignancy.
OB/GYN and Women\'s Health
Clinical Evaluation: The first stage entails a thorough examination of the patient’s medical records and a comprehensive physical assessment. If symptoms like abdominal swelling, pleuritic chest discomfort, and difficulty in breathing are observed, it could indicate the possibility of this syndrome.
Imaging: Radiological techniques like ultrasound, CT scans, or MRI can be employed to visualize the ovarian mass, confirm the presence of ascites and pleural effusion, and rule out other potential causes of these symptoms.
Laboratory Tests: Blood tests, including tumor markers (e.g., CA-125), may be performed to aid in the diagnosis and rule out malignancy.
Treatment:
Surgery: The main approach to address this syndrome involves the surgical extraction of the ovarian tumor. This procedure is often performed via laparotomy or laparoscopy, depending on the size and characteristics of the tumor. In most cases, the tumor is benign (fibroma) and can be completely excised.
Paracentesis: In cases of significant ascites, a medical procedure known as paracentesis, this process entails extracting fluid from the abdominal cavity, can be undertaken to alleviate symptoms and enable surgical interventions.
Thoracentesis: If pleural effusion is causing respiratory distress, thoracentesis (draining of fluid from the pleural space) may be necessary to improve lung function.
Histopathological Examination:
The excised ovarian tumor is sent for histopathological examination to confirm its benign nature and rule out malignancy.
Postoperative Care:
After surgery, patients are closely monitored for any complications, and pain management and wound care are provided as necessary.
Patients with significant pleural effusion or ascites may require ongoing management to address these issues.
Follow-up:
Regular post-treatment check-ups are crucial for overseeing the patient’s recuperation and preventing any reoccurrence of this medical condition.
Imaging studies and clinical assessments may be scheduled at specified intervals to check for any signs of tumor recurrence or other complications.
Patient Education and Support:
Patients should be educated about their condition, treatment, and follow-up care’s importance.
Meigs’ syndrome is a rare medical condition characterized by a triad of symptoms that typically incorporate the existence of a non-malignant ovarian growth, pleural effusion, and ascites. This syndrome was first described by the American gynecologist Joe Vincent Meigs in 1937, and its recognition has since played a crucial role in gynecology and oncology.
Meigs’ syndrome often presents a diagnostic challenge due to its similarity to other more severe conditions, such as ovarian cancer, making accurate diagnosis and prompt intervention essential for patient care.
Incidence:
Meigs syndrome is rare, accounting for a small fraction of ovarian tumors and pleural effusions.
Meigs syndrome occurs in approximately 1% of all ovarian tumors and is most frequently linked with ovarian fibromas, identified in 2-5% of surgically removed ovarian tumors.
The exact incidence of this syndrome is not well-established due to its rarity.
Age and Gender:
Meigs syndrome most commonly affects women, with most reported cases occurring in females.
It predominantly occurs in women between 30 and 60 years, although it can affect women of all ages.
Tumor Type:
The ovarian tumor associated with this syndrome is typically a benign fibroma.
Other less common ovarian tumors, such as thecoma or granulosa cell tumors, can also be associated with this syndrome.
Tumor Growth:
Meigs Syndrome typically occurs in women with a benign ovarian tumor, most commonly a fibroma. These tumors are solid and arise from the connective tissue of the ovary.
As the tumor grows, it can compress blood vessels and lymphatic vessels within the ovary, leading to impaired blood and lymphatic drainage from the affected ovary.
Increased Permeability:
The ovarian tumor may stimulate the release of certain substances or inflammatory mediators to enhance the blood vessels permeability within the tumor and the surrounding tissues.
This increased permeability can leak fluid, protein, and blood components into the abdominal cavity (ascites) and the pleural space (pleural effusion).
Fluid Accumulation:
Ascites develops due to the buildup of fluid within the peritoneal cavity. The increased permeability of blood vessels allows fluid to escape into the abdominal space.
Pleural effusion occurs when fluid leaks into the pleural space around the lungs. This can cause compression of the lungs, leading to breathing difficulties.
Ovarian Tumor Characteristics:
The specific characteristics of the ovarian tumor, such as its size and location, can contribute to developing this Syndrome. Larger tumors are more likely to cause compression and vascular compromise.
Fibromas are usually slow-growing and benign, so they do not invade surrounding tissues or metastasize.
Ovarian Tumor: Meigs syndrome is primarily characterized by the occurrence of a non-cancerous ovarian growth, usually identified as a fibroma. However, other types of tumors like thecoma or granulosa cell tumors can also be involved. These tumors arise from the connective tissue or stromal cells of the ovary.
Pleural Effusion: Meigs syndrome also involves the accumulation of fluid within the pleural cavity, known as pleural effusion. This can lead to chest pain, cough, and shortness of breath.
Ascites is fluid accumulation within the peritoneal cavity, causing abdominal distention and discomfort. In this syndrome, ascites is often present along with pleural effusion.
Tumor Pressure: The presence of the ovarian tumor can exert pressure on nearby blood vessels and lymphatic channels. This pressure may disrupt the normal flow of fluids within the body, leading to ascites and pleural effusion.
Inflammatory Mediators: Some researchers suggest that the tumor itself may produce inflammatory mediators or substances that contribute to fluid accumulation in the peritoneal and pleural spaces.
Tumor Characteristics: The size and nature of the ovarian tumor play a crucial role in the prognosis. Larger tumors may be associated with more severe symptoms and complications, potentially affecting the prognosis.
Tumor Histology: The histological type of the ovarian tumor can influence the prognosis. Most Meigs syndrome cases involve benign fibromas, which have an excellent prognosis. However, in rare cases, ovarian malignancies may mimic this syndrome, leading to a worse prognosis.
Underlying Health Status: The patient’s overall health, including other medical conditions, can influence the prognosis and the ability to tolerate surgery and treatment.
Age group
Meigs syndrome primarily affects adults, typically in women in their reproductive years or postmenopausal. The age group for meigs syndrome is most commonly between 30 and 50 years old. However, it’s important to note that this is a general age range, and cases outside of this range can still occur, albeit less frequently.
Abdominal Examination:
Abdominal Distension: The most prominent physical finding in this syndrome is abdominal distension due to the accumulation of ascitic fluid. The abdomen may appear enlarged and tense.
Palpable Pelvic Mass: A firm, non-tender pelvic mass, often arising from one of the ovaries (usually a fibroma), may be palpable during a pelvic examination.
Tenderness: Some patients may experience mild tenderness or discomfort in the lower abdomen, especially if the mass is large or if there is associated torsion or inflammation.
Imaging Studies: Ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) can help confirm the presence of an ovarian mass and assess the extent of ascites and pleural effusion.
Laboratory Tests: Routine blood tests can show elevated cancer markers (e.g., CA-125), but these markers are not specific to this syndrome.
Histopathology: Definitive diagnosis often requires surgical removal of the ovarian mass, followed by histopathological examination to confirm the presence of a benign tumor.
Subtle or Insidious Onset:
Meigs syndrome can sometimes have a slow and insidious onset, with symptoms developing gradually over weeks or even months.
Patients may initially experience mild discomfort or bloating in the lower abdomen.
Abdominal Discomfort:
Many individuals with this syndrome complain of abdominal discomfort or pain, which may be intermittent or persistent.
This discomfort is often located in the lower abdomen and may be mistaken for gastrointestinal issues.
Ascites:
Ascites is the condition characterized by the fluid accumulation within the abdominal cavity, represents a distinguishing characteristic of this syndrome.
As ascites worsens, patients may notice abdominal distension, weight gain, and a feeling of fullness.
Pleural Effusion:
pleural effusion is the fluid accumulation around the lungs, may lead to various symptoms including coughing, difficulty breathing, and chest discomfort.
These respiratory symptoms may be subtle initially but can become more pronounced as the pleural effusion worsens.
Elevated CA-125 Levels:
In some cases, blood tests may reveal elevated levels of CA-125, a tumor marker associated with ovarian cancer. This can further complicate the diagnosis.
Ovarian Tumor: The presence of a benign ovarian tumour, most frequently a fibroma, is the leading cause of this disease. These tumors can grow quite large and cause abdominal discomfort or pain.
Pleural Effusion: Another feature of this syndrome involves the fluid accumulation in the pleural cavity, which is the area surrounding the lungs. This medical condition is referred to as pleural effusion and can result in manifestations like difficulty in breathing, chest discomfort, or an ongoing cough.
Ascites: Ascites is the fluid accumulation within the abdominal cavity, leading to abdominal swelling and discomfort.
Ovarian Cancer: Ovarian cancer can present with similar symptoms, including pleural effusion and ascites. Differentiating between benign ovarian tumors and ovarian cancer is crucial, and this often requires imaging studies, biopsy, and tumor markers (e.g., CA-125).
Tuberculosis (TB): TB can cause pleural effusion and ascites. It is especially important to consider TB in regions where it is prevalent.
Liver Cirrhosis: Cirrhosis can result in ascites due to liver dysfunction and increased abdominal pressure. It can also lead to pleural effusion in some cases.
Peritoneal Carcinomatosis: It involves spreading cancer cells throughout the peritoneal cavity, causing ascites and sometimes pleural effusion.
Nephrotic Syndrome: This kidney disorder can lead to generalized edema, including pleural effusion and ascites.
Endometriosis: Although less common, endometriosis can present with ovarian masses and ascites.
Diagnosis and Evaluation:
The diagnosis of this syndrome is typically made based on clinical presentation, imaging studies (ultrasound, CT scan), and laboratory tests.
Ascitic fluid analysis and pleural fluid analysis are essential to rule out malignancy.
Stabilization:
If the patient is in respiratory distress due to pleural effusion, initial stabilization may involve pleural fluid drainage to relieve respiratory symptoms.
Surgical Intervention:
The primary treatment for this syndrome is surgical removal of the ovarian tumor (ovarian cystectomy or oophorectomy).
A laparoscopic approach is often preferred when feasible, resulting in reduced postoperative pain and quicker recovery periods.
Histological Examination:
The removed ovarian tumor should be sent for histological examination to confirm its benign nature, a characteristic of this syndrome.
Resolution of Ascites and Pleural Effusion:
Following the surgical excision of the ovarian mass, ascites and pleural effusion typically resolve rapidly over the following weeks.
Continued monitoring with imaging studies and clinical evaluation is essential to confirm resolution.
Follow-Up:
Postoperative follow-up is crucial to monitor for any ascites or pleural effusion recurrence.
Long-term surveillance may also be necessary to detect any potential complications or recurrence of the ovarian tumor.
Supportive Care:
Patients may require supportive care during their recovery, including pain management, nutritional support, and respiratory therapy if respiratory compromise was severe before surgery.
Consideration of Malignancy:
In rare cases, this syndrome may mimic malignant conditions, so a careful evaluation and workup are essential to rule out ovarian malignancies.
OB/GYN and Women\'s Health
Postoperative Care:
After surgery ensure that the patient’s room is kept clean, and infection control measures are strictly followed.
Rehabilitation:
Individuals in the process of post-surgical recovery can experience improved strength and mobility through the utilization of physical therapy and rehabilitation services.
The environment for rehabilitation should be equipped with appropriate exercise equipment and supportive care.
Emotional Support:
Meigs syndrome and its treatment can be physically and emotionally challenging. Providing a supportive and empathetic environment is crucial.
Considerations for counseling services or support groups may benefit patients and their families.
Nutritional Support:
Patients recovering from this syndrome may need specialized diets or nutritional support to aid in their recovery.
Ensure that the hospital or care facility can provide appropriate dietary options.
Home Environment:
After discharge from the hospital, patients may need modifications to their home environment to accommodate their recovery needs, such as handrails or adaptive equipment.
Home healthcare services may be necessary for individuals who require ongoing medical care and monitoring.
OB/GYN and Women\'s Health
Surgical Consultation: Refer the patient to a gynecologic surgeon or a surgical oncologist experienced in managing this Syndrome.
Surgery: Typically, surgery is the primary treatment for Meigs Syndrome. The procedure may involve unilateral or bilateral salpingo-oophorectomy (surgical extraction of the affected ovary and associated fallopian tube.) and the removal of the ovarian fibroma.
laparotomy: A laparotomy for Meigs Syndrome is a surgical procedure performed to treat this rare condition, which typically involves the removal of a tumor associated with this Syndrome, such as a fibroma, along with the removal of a large amount of ascitic fluid that has accumulated in the abdominal cavity. This procedure aims to relieve symptoms and improve the patient’s overall health.
Postoperative Care:
Monitoring: After surgery, closely monitor the patient’s recovery in the hospital, including vital signs, pain management, and fluid balance.
Pathological Examination: Analyze the biopsy samples to confirm the presence of ovarian fibroma and rule out malignancy.
OB/GYN and Women\'s Health
Clinical Evaluation: The first stage entails a thorough examination of the patient’s medical records and a comprehensive physical assessment. If symptoms like abdominal swelling, pleuritic chest discomfort, and difficulty in breathing are observed, it could indicate the possibility of this syndrome.
Imaging: Radiological techniques like ultrasound, CT scans, or MRI can be employed to visualize the ovarian mass, confirm the presence of ascites and pleural effusion, and rule out other potential causes of these symptoms.
Laboratory Tests: Blood tests, including tumor markers (e.g., CA-125), may be performed to aid in the diagnosis and rule out malignancy.
Treatment:
Surgery: The main approach to address this syndrome involves the surgical extraction of the ovarian tumor. This procedure is often performed via laparotomy or laparoscopy, depending on the size and characteristics of the tumor. In most cases, the tumor is benign (fibroma) and can be completely excised.
Paracentesis: In cases of significant ascites, a medical procedure known as paracentesis, this process entails extracting fluid from the abdominal cavity, can be undertaken to alleviate symptoms and enable surgical interventions.
Thoracentesis: If pleural effusion is causing respiratory distress, thoracentesis (draining of fluid from the pleural space) may be necessary to improve lung function.
Histopathological Examination:
The excised ovarian tumor is sent for histopathological examination to confirm its benign nature and rule out malignancy.
Postoperative Care:
After surgery, patients are closely monitored for any complications, and pain management and wound care are provided as necessary.
Patients with significant pleural effusion or ascites may require ongoing management to address these issues.
Follow-up:
Regular post-treatment check-ups are crucial for overseeing the patient’s recuperation and preventing any reoccurrence of this medical condition.
Imaging studies and clinical assessments may be scheduled at specified intervals to check for any signs of tumor recurrence or other complications.
Patient Education and Support:
Patients should be educated about their condition, treatment, and follow-up care’s importance.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
